# Corino Therapeutics, Inc. — Form D

Corino Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-27. The offering totals $5.0M, of which $3.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-04-27
- Form: D
- Accession: 0001703341-17-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.5M
- Remaining: $1.5M
- Investors: 27
- Date of first sale: 2017-04-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-285612

## Issuer

- Name: Corino Therapeutics, Inc.
- CIK: 0001703341
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: PETER BARBER, NEW YORK, NY, 10019
- Phone: (212) 430-1740

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Peter Barber | Director | New York, NY |
| Daniel DiPietro | Director | New York, NY |
| Timothy McInerney | Director | New York, NY |
| Jay Moorin | Director | New York, NY |
| Daniel DiPietro | Executive Officer | New York, NY |

## More

- [CIK 1703341 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1703341&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001703341-17-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.